Table 1.
Patient’s clinical characteristics and outcomes
| Parameters | Cervical cancer (n=33) |
|---|---|
|
| |
| Clinical characteristics | |
| Age, year, mean±SD | 48.27±9.30 |
| Pathological type, n (%) | |
| Squamous cell carcinoma | 18 (54.5) |
| Adenocarcinoma | 8 (24.2) |
| Adenosquamous carcinoma | 7 (21.2) |
| FIGO stage, n (%) | |
| Stage I | 18 (54.5) |
| Stage II | 15 (45.5) |
| Stage III | 0 |
| Histologic grade, n (%) | |
| G1 | 2 (6.1) |
| G2 | 25 (75.8) |
| G3 | 6 (18.2) |
| Lymphatic metastasis | 10 (30.3) |
| SATB1 expression levels | 4.91±1.85 |
| Clinical outcomes, n (%) | |
| Death | 3 (9.1) |
| Progression | 6 (18.2) |
| Recurrence, n (%) | |
| No | 27 (81.8) |
| Local recurrence | 3 (9.1) |
| Distant metastasis | 2 (6.1) |
| Local recurrence and distant metastasis | 1 (3.0) |
Abbreviation: FIGO, International Federation of Gynecology and Obstetrics.